RxDoctor Payments DataLook up a doctor →

Alexander Spira, MD

Medical Oncology · Fairfax, VANPI 1902874514

Payments from drug & device makers

$69,492,595in general payments, 2019–2025

Across 8,101 payments — averaging $8578.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$10M
  • AstraZeneca$7.4M
  • Daiichi Sankyo Inc.$7.4M
  • Mirati Therapeutics, Inc.$6.8M
  • AbbVie$3.2M
  • Novartis$2.6M
  • plus $31.9M from 54 others
$150,875in research payments, 2019–2025

Across 81 payments — averaging $1862.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orphai Therapeutics Inc.$63K
  • Novartis$23K
  • Boehringer Ingelheim International GmbH$22K
  • Macrogenics, Inc.$9K
  • Regeneron$8K
  • Amgen$7K
  • plus $19K from 6 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC768$10,008,985
AstraZeneca(2 entities)205$7,373,935
Daiichi Sankyo Inc.1,429$7,356,617
Mirati Therapeutics, Inc.557$6,817,839
AbbVie571$3,240,344
Novartis47$2,624,763
Takeda Pharmaceuticals U.S.A., Inc.255$2,523,894
E.r. Squibb & Sons, L.L.C.121$2,216,275
Amgen86$2,178,276
Genentech, Inc.349$2,157,034
Daiichi Sankyo Company LTD54$2,089,164
Merck73$2,021,576
Eli Lilly41$1,809,897
Pfizer123$1,568,122
Blueprint Medicines Corporation128$1,468,358
Astrazeneca UK Limited41$1,390,135
Astellas Pharma Inc774$1,343,060
Biontech SE321$1,183,715
Otsuka Pharmaceutical Co., Ltd.48$1,001,622
Aadi Bioscience, Inc.19$960,802
GSK156$764,884
Alkermes, Inc.110$758,146
Boehringer Ingelheim97$644,763
Macrogenics, Inc.85$586,450
Chugai Pharmaceutical Co., Ltd.176$577,272
Regeneron97$520,411
Boehringer Ingelheim Pharma GmbH & Co.kg44$422,954
Seagen Inc.205$416,675
Genmab U.S., Inc.71$413,779
Incyte Corporation150$395,835
Taiho Oncology, Inc.40$229,556
Bayer22$200,070
EMD Serono, Inc.191$193,542
Ipsen Pharma SAS58$183,691
Bristol Myers Squibb16$171,061
Deciphera Pharmaceuticals Inc.18$142,389
Merck Healthcare Kgaa41$135,374
Beone Medicines USA, Inc.10$129,866
Beigene, Ltd.24$126,941
Dynavax Technologies Corporation14$95,539
Ascendis Pharma Endocrinology Inc10$90,687
Beone Medicines Ltd.4$76,265
Puma Biotechnology, Inc.34$64,039
Johnson & Johnson(2 entities)69$60,371
Astellas Pharma Global Development7$58,539
Teva Pharmaceuticals USA, Inc.22$52,593
F. Hoffmann-la Roche AG24$47,706
Foundation Medicine, Inc.25$44,775
Sanofi US Services Inc.6$44,739
Tesaro, Inc.14$43,060
G1 Therapeutics, Inc.3$40,141
Trillium Therapeutics USA, LLC7$38,600
Spectrum Pharmaceuticals Inc.16$35,484
Pharmacyclics LLC, An Abbvie Company8$33,516
Clovis Oncology, Inc.1$32,083
Stemline Therapeutics Inc.10$31,183
Servier Bioinnovation6$30,500
Janssen Global Services, LLC9$26,863
Sanofi5$22,467
EMD Serono Research & Development Institute, Inc.22$22,102

How this compares

$69,492,595 in reported general payments places this provider in the 95th percentile of 95 medical oncology providers in Virginia.

See all medical oncology providers in Virginia

Medicare billing

Part B allowed, 2024
$2,573,679
Medicare patients
1,073
Services billed
122,350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →